The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key markets has introduced significant volatility. Investors are now facing the impact of lower-cost alternatives, dimi